How many SEC Form 4 insider filings does TAK have?

TAKEDA PHARMACEUTICAL CO LTD (TAK) has 22 SEC Form 4 filings (24 transaction rows) in the rolling 365-day window, disclosed by 0 distinct insiders. Most recent filing: Jul 6, 2026.

When was the most recent SEC Form 4 filing for TAK?

The most recent Form 4 filing for TAK on Tracefour is dated Jul 6, 2026.

TAK

Name: TAK Insider Trading Activity
Creator: Tracefour
License: https://www.usa.gov/government-works
Keywords: TAK, insider trading, SEC Form 4, insider transactions

TAKEDA PHARMACEUTICAL CO LTD

TAKEDA PHARMACEUTICAL CO LTD (TAK) has 22 SEC Form 4 filings (24 transaction rows) in the rolling window, disclosed by 0 distinct insiders. Most recent filing: Jul 6, 2026.

Industry:Drug Manufacturers - Specialty & Generic
CEO:Christophe Weber
Employees:49,281
HQ:Tokyo, JP
IPO:2010-01-05

No open-market insider trades for TAK (TAKEDA PHARMACEUTICAL CO LTD) in the last 365 days.

Why this page may be quiet. Tracefour displays Form 4 open-market purchases (P) and sales (S): the two transaction codes that signal directional conviction. Restricted stock grants, option exercises, gifts, and tax-withholding sales are filed but intentionally not shown: they're disclosure mechanics, not buy/sell decisions.

Many large-cap executives trade through pre-scheduled 10b5-1 plans set months in advance and batch-disclosed each quarter, so the latest filing on EDGAR for a mega-cap can be weeks old without any insider actually choosing to trade in that window.

See all Form 4 filings on SEC EDGAR ↗

Related companies

TAKEDA PHARMACEUTICAL CO LTD is in the Healthcare sector.